Angiotensin-converting enzyme inhibitors (ACEIs): Cleland et al. [34] suggested in the PEP-CHF trial that using Perindopril in elderly HFpEF patients improved HF symptoms and exercise capacity and reduced HF hospitalizations. This evidence concerns the gene ACE and hydrops fetalis.